Los Angeles Times6h
Working to End the HIV Epidemic Through Innovation, Equity, Collaboration & Choice
Gilead is committed to designing trials to help understand how HIV treatment and prevention impact populations that have been ...
Le Lézard6h
Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow
Gilead Sciences, Inc. today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is studying twice-yearly lenacapavir, the company's ...
CDC: U.S. epidemic of STDs may finally be slowing
The epidemic of sexually transmitted infections (STIs) in the United States appears to be cooling off after more than two ...
Science Daily16h
Combination approach shows promise for treating rare, aggressive cancers
A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell ...
Hosted on MSN17h
America's Epidemic of STDs May Finally Be Slowing
TUESDAY, Nov. 12, 2024 -- The epidemic of sexually transmitted infections (STIs) in the United States appears to be cooling ...
Clinical trial shows immunotherapy drug pembrolizumab improves outcomes for patients with soft tissue sarcoma
Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...
WCVB Channel 5 Boston14h
There are millions of sexually transmitted infections in the US every year, but new data shows the epidemic may be slowing
new study has indicated the United States is currently in the throes ... director of the CDC's National Center for HIV, Viral ...
The American Journal of Managed Care3h
β-Blockers May Raise Depression Risk for Heart Attack Survivors Without Heart Failure
One study suggests these drugs could increase depression risk in heart attack survivors who retained normal heart pumping ...
Sudden syphilis retreat in gay men is most likely tied to preventive antibiotic use
A new proven protocol in which doxycycline is used to prevent sexually transmitted infections — called doxyPEP — has been an ...
Business Insider20h
Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
representing a significant step forward in our clinical development as we plan the first clinical trial combining BeiGene's anti-PD-1 antibody, tislelizumab, with Indaptus’ Decoy20 product candidate ...
Scientist cures stage 3 cancer without chemo using lab-grown viruses, docs say unethical
A scientist who was diagnosed with stage 3 cancer treated herself using lab-grown viruses, a method researchers say is 'not ...
Gene Therapy for SCID Market is Expected to Reach at a US$ 2.0 Billion by 2034 | Fact.MR Report
High Investment and Government Initiatives to Boost Rare Diseases Treatment ModalitiesRockville, MD, Nov. 13, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive ...